17 November 2017Americas

Texas universities sue J&J subsidiary over biodegradable fibres

A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Texas uni loses bid to shield cancer vaccine patents from IPRs

18 February 2021 The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.

Educational institutions in cancer patent spat

5 April 2017 The Board of Regents of the University of Texas System and cancer research company Gensetix have filed a patent complaint against Baylor College of Medicine, Diakonos Research and an inventor called William Decker.

More on this story

Biotechnology

Texas uni loses bid to shield cancer vaccine patents from IPRs

18 February 2021 The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.

Educational institutions in cancer patent spat

5 April 2017 The Board of Regents of the University of Texas System and cancer research company Gensetix have filed a patent complaint against Baylor College of Medicine, Diakonos Research and an inventor called William Decker.

More on this story

Biotechnology

Texas uni loses bid to shield cancer vaccine patents from IPRs

18 February 2021 The University of Texas has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews.

Educational institutions in cancer patent spat

5 April 2017 The Board of Regents of the University of Texas System and cancer research company Gensetix have filed a patent complaint against Baylor College of Medicine, Diakonos Research and an inventor called William Decker.

More features

The flaw that landed Sanofi a win in the rare disease space

Roche resolves cancer test dispute with Stanford affiliated startup

Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory

UK firm expands in Germany with more litigation hires

Sandoz blocked by UK court from seeking Xarelto profits

An update on patenting in Ukraine, Russia and Eurasia

The rise of pro-NPE and patent sentiment in the US

UPC sees rising small molecule litigation with Pfizer in the hot seat